BIO-ATORVASTATIN

biomed pharma🇨🇦 Health Canada

Approval Id: 6122c625bb2cffc6
Drug Approval Canada Name: BIO-ATORVASTATIN
Product Name: BIO-ATORVASTATIN
Status: Marketed
Status Date: 2024-04-23
Original Market Date: 2019-09-24
Din: 02481219
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA05 ATORVASTATIN
Atc Name: c 10 aa 05
Aig Number: 0133055004
Company Name: biomed pharma
Company Address: 1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8

ATORVASTATIN (ATORVASTATIN CALCIUM)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6122c625bb2cffc6

Type

Standard